Responsible nanobiotechnology: Philosophy and ethics

Responsible Nanobiotechnology: Philosophy and Ethics

Volumn , Issue , 2012, Pages

  Grunwald, Armin ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881811660     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4032/9789814364331     Document Type: Book

References (391)

1. Abbott, A. (2006) Neuroprosthetics: in search of the sixth sense. Nature 442, 125-127.
2. Ach, J., Pollmann, A. (eds.) (2006) No Body Is Perfect: Baumaßnahmen am menschlichen Körper-Bioethische und ästhetische Aufrisse, Bielefeld.
3. Ach, J., Siep, L. (eds.) (2006) Nano-bio-ethics: Ethical and Social Dimensions of Nanobiotechnology, Berlin.
4. Allhoff, F. (2007) On the autonomy and justification of nanoethics. NanoEthics 1, 185-210.
5. Allhoff, F., Lin, P. (2006) What's so special about nanotechnology and nanoethics? International Journal of Applied Philosophy 20, 179-190.
6. Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.) (2007) Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey.
7. Altmann, J. (2006) Military Nanotechnology: Potential Application and Preventive Arms Control, London.
8. Altmann, J., Gubrud, M. A. (2002) Risks from military uses of nanotechnology: the need for technology assessment and preventive control. In: Roco, M. C., Tomellini, R. (eds.), Nanotechnology: Revolutionary Opportunities and Social Implications, Luxembourg, pp. 144-148.
9. Anders, G. (1964) Die Antiquiertheit des Menschen, München.
10. Attfield, R. (1995) Genetic engineering: can unnatural kinds be wronged? In: Wheale, P., McNally, R. (eds.), Animal Genetic Engineering: Of Pigs, Oncomice and Men, London, pp. 201-210.
11. Bachmann, A. (2006) Nanobiotechnologie: Eine ethische Auslegeordnung, Bern.
12. Bachmann, G. (1998) Innovationsschub aus dem Nanokosmos, Technologieanalyse Nr. 28, Düsseldorf.
13. BAFU-Bundesamt für Umwelt (2007) Synthetische nanomaterialien: Risikobeurteilung und Risikomanagement, Bern
14. Bainbridge, W. S. (2004) Progress toward cyberimmortality. In: Immortality Institute (Hg.), The Scientific Conquest of Death, Buenos Aires, pp. 107-122 (www.imminst. org/book1/).
15. Baird, D., Nordmann, A., Schummer, J. (eds.) (2004) Discovering the Nanoscale, Amsterdam.
16. Balaban, T., Buth, G. (2005) Biomimetische lichtsammlung. FZK - Nachrichten 37, Nr. 4, S. 204-209; see also other work of these authors.
17. Ball, P. (2003) Nanoethics and the Purpose of New Technologies, London (http://www.whitebottom.com/philipball/docs/Nanoethics.doc).
18. Ball, P. (2005) Synthetic biology for nanotechnology. Nanotechnology 16, R1-R8.
19. Banse, G., Grunwald, A., Hronszky, I., Nelson, G. (eds.) (2008) Assessing Societal Implications of Converging Technological Development, Berlin.
20. Barthlott, W. (1990) Scanning electron microscopy of the epidermal surface in plants. Systematics Association's Special 41, 69-94.
21. Baumgartner, C. (2006) Nanotechnologie in der Medizin als Gegenstand ethischer Reflexion: Problemfelder, Herausforderungen, Implikationen. In: Nordmann, A., Schummer, J., Schwarz, A. (eds.), Nanotechnologien im Kontext, Berlin, pp. 325-343.
22. Bayertz, K. (ed.) (2004) Die menschliche Natur: Welchen und wie viel Wert hat sie? Paderborn.
23. Bechmann, G. (1993) Ethische Grenzen der Technik oder technische Grenzen der Ethik? Geschichte und Gegenwart 12, 213-225.
24. Beck, U. (1986) Risikogesellschaft: Auf dem Weg in eine andere Moderne, Frankfurt. English version: Risk Society: Towards a New Modernity, London, 1992.
25. Benner, S. A., Sismour, A. M. (2005) Synthetic biology. Nature Reviews Genetics 6(7), 533-543.
26. Bensaude-Vincent, B. (2004) Two cultures of nanotechnology? HYLE - International Journal for Philosophy of Chemistry 10, 65-82.
27. Bensaude-Vincent, B. (2009) Philosophy of Chemistry, Boston Studies in the Philosophy of Science, Vol. 276, Part III, pp. 165-189.
28. Berlosznik, R. (2007) Meeting of minds: a European participatory project. In: Bora, A., Bröchler, S., Decker, M. (eds.), Technology Assessment in der Weltgesellschaft, Berlin.
29. Beyerlein, F. (2000) Nano-Medizin und Gesundheitsvorsorge im 21, Jahrhundert. Tausend Jahre leben, Magazin 2000 plus, Medizin 2.
30. Bhaskar, S., Tian, F., Stoeger, T., Kreyling, W., de la Fuente, J. M., Grazu, V. (2010) Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicology 2010.
31. Bhutkar, A. (2005) Synthetic biology: navigating the challenges ahead. The Journal of Biolaw & Business 8(2), 19-28.
32. Bijker, W. E., Hughes, T. P., Pinch, T. J. (eds.) (1987) The Social Construction of Technological Systems: New Directions in the Sociology and History of Technological Systems, Cambridge (Mass.)/London.
33. Birnbacher, D. (1988) Verantwortung für zukünftige Generationen, Stuttgart.
34. BMBF - Bundesministerium für Bildung und Forschung (2002) Standortbestimmung: Nanotechnologie in Deutschland, Berlin
35. Boldt, J., Müller, O. (2008) Newtons of the leaves of grass. Nature Biotechnology 26, 387-389.
36. Boldt, J., Müller, O., Maio, G. (2009) Synthetische Biologie: Eine Ethisch-Philosophische Analyse, Bern.
37. Böschen, S., Kratzer, N., May, S. (eds.) (2006) Nebenfolgen: Analyse zur Konstruktion und Transformation moderner Gesellschaften, Weilerswist.
38. Bostrom, N., Savalescu, J. (2009) Human Enhancement, Oxford.
39. Brenner, A. (2007) Leben: Eine philosophische Untersuchung, Bern.
40. Brown, C. (2004) BioBricks to help reverse-engineer life. EE Times, June 11, 2004.
41. Brown, N., Rappert, B., Webster, A. (eds.) (2000) Contested Futures: A Sociology of Prospective Techno-Science, Burlington.
42. Brown-Weiss, E. (1989) In Fairness to Future Generations: International Law, Common Patrimony and Intergenerational Equity, New York.
43. Bruggeman, F. J., Westerhoff, H. V. (2006) The nature of system biology. Trends in Microbiology 15, 45-50.
44. BUND - Bund für Umwelt und Naturschutz in Deutschland (2008) Aus dem Labor auf den Teller: Die Nutzung der Nanotechnologie im Lebensmittelsektor (http://www.bund.net/fileadmin/bundnet/publikationen/nanotechnologie/20080311_nanotechnologie_lebensmittel_studie.pdf).
45. BUND - Bund für Umwelt und Naturschutz in Deutschland (2009) Nanosilber - der Glanz täuscht (http://www.bund.net/fileadmin/bundnet/publikationen/nanotechnologie/20091202_nanotechnologie_nanosilber_studie.pdf).
46. Bunge, M. (2003) Emergence and Convergence: Qualitative Novelty and the Unity of Knowledge, Toronto.
47. Burns, T. R., Ueberhorst, R. (1988) Creative Democracy: Systematic Conflict Resolution and Policymaking in a World of High Science and Technology, New York.
48. Caplan, P. (2000) Risk Revisited, London.
49. Caplan, P. (2009) Do Synthetic Biologists Play God? (http://www.synbiosafe.eu/uploads///pdf/09_03_SiscoveryTech_Do_Synthetic_Biologists_Play_God.pdf).
50. Capurro, R. (2004) Informationsethik. Eine Standortbestimmung. Wechselwirkung 25, 132-139; Towards an information ecology. In: Wormell, I. (ed.) (1990), Information and Quality, London, pp. 122-139.
51. Cauller, L., Penz, A. (2002) Artificial brains and natural intelligence. In: Roco, M. C., Bainbridge, W. S. (eds.), Converging Technologies for Improving Human Performance, Virginia, pp. 227-230.
52. Chakrabarty, A. M. (2003) Crossing species boundaries and making humannonhuman hybrids: moral and legal ramiacations. The American Journal of Bioethics 3(3), 20-21.
53. Cheng, J., Fleming, G. (2009) Dynamics of light harvesting in photosynthesis. Annual Review of Physical Chemistry 60, 242-261.
54. Choksi, A. N., Poonawalla, T., Wilkerson, M. G. (2010) Nanoparticles: a closer look at their dermal effects. The Journal of Drugs in Dermatology 9(5), 475-481.
55. Chopra, P., Kamma, A. (2006) Engineering life through synthetic biology. Silico Biology 6, 401-410.
56. Church, G. (2005) Let us go forth and safely multiply. Nature 438, 423.
57. Clausen, J. (2006) Ethische Aspekte von Gehirn-Computer-Schnittstellen in motorischen Neuroprothesen. International Review of Information Ethics 5, 25-32.
58. Clausen, J. (2009) Ethische Fragen aktueller Neurowissenschaften: Welche Orientierung gibt die »Natur des Menschen«? In: Hildt, E., Engels, E.-M. (eds.), Der implantierte Mensch, Freiburg.
59. Coenen, C. (2006) Der posthumanistische Technofuturismus in den Debatten über Nanotechnologie und Converging Technologies. In: Nordmann, A., Schummer, J., Schwarz, A. (eds.), Nanotechnologien im Kontext, Berlin, pp. 195-222.
60. Coenen, C. (2008a) Konvergierende Technologien und Wissenschaften: Der Stand der Debatte und politische Aktivitäten zu »Converging Technologies«, Berlin (summary in English: www.itas.fzk.de/deu/lit/ 2008/coen08a_summary.htm).
61. Coenen, C. (2008b) Von der Leistungs: zur Leistungssteigerungsgesellschaft? TAB-Brief 33, Berlin, Büro für Technikfolgen-Abschätzung, pp. 21-27.
62. Coenen, C. (2010) Deliberating visions: the case of human enhancement in the discourse on nanotechnology and convergence. In: Kaiser, M., Kurath, M., Maasen, S., Rehmann-Sutter, Chr. (eds.), Governing Future Technologies: Nanotechnology and the Rise of an Assessment Regime, Springer, pp. 73-87.
63. Coenen, C., Schuijff, M., Smits, M., Klaassen, P., Hennen, L., Rader, M., Wolbring, G. (2009) Human Enhancement, Brussels, European Parliament (http://www.itas.fzk.de/deu/lit/2009/coua09a.pdf).
64. Coenen, Chr., Hennen, L., Link, H.-J. (2009) The ethics of synthetic biology: contours of an emerging discourse. Technikfolgenabschätzung: Theorie und Praxis 18(2), 82-86.
65. Coffrin, T., MacDonald, C. (2004) Ethical and social issues in nanotechnology. Annotated bibliography (http://www.ethicsweb.ca/nanotechnology/ bibliography.html).
66. COGEM (2006) Synthetische Biologie: Een Onderzoeksveld Met Voortschrijdende Gevolgen (http://www.cogem.net/pdfdb/advies/CGM060228-03.pdf).
67. Collingridge, D. (1980) The Social Control of Technology, London.
68. Colorado Public Commission (1992) Statement of adoption in the matter of the rules for electric utilities of the Colorado Public Utilities Commission. Code of Colorado Regulation-723-3 concerning electric and magnetic fields, Denver CPUC.
69. Colvin, V. (2003) Responsible Nanotechnology: Looking Beyond the Good News. Centre for Biological and Environmental Nanotechnology at Rice University (http://www.eurekalert.org/).
70. Comstock, G. (2000) Vexing Nature? On the Ethical Case against Agricultural Biotechnology, Boston, Dordrecht, London.
71. Court, E., Salamance-Buentello, F., Singer, P. A., Daar, A. S. (2007) Nanotechnology and the developing world. In: ten Have, H. (ed.), Nanotechnologies, Ethics, and Politics, UNESCO Publishing, pp. 155-180.
72. Dabrock, P. (2009) Playing God? Synthetic biology as a theological and ethical challenge. Systems and Synthetic Biology 3, 47-54.
73. Danish Council of Bioethics (2008) Man or Mouse? Ethical Aspects of Chimaera Research, The Danish Council of Bioethics (http://www.etiskraad.dk/sw16983.asp).
74. de Vriend, H. (2006) Constructing Life: Early Social Reflections on the Emerging Field of Synthetic Biology, Rathenau Institute, The Hague.
75. Deblonde, M., van Oudheusden, M., Evers, J., Goorden, L. (2011) Co-creating nano-imaginaries. Results of a Delphi. Bulletin of Science, Technology and Society 31 (in press).
76. Decker, M. (2006) Eine Definition von Nanotechnologie: Erster Schritt für ein interdisziplinäres Nanotechnology Assessment. In: Nordmann, A., Schummer, J., Schwarz, A. (eds.), Nanotechnologien im Kontext, Berlin, pp. 33-48.
77. Decker, M., Fiedeler, U., Fleischer, T. (2004) Ich sehe was, was Du nicht siehst. zur Definition von Nanotechnologie. Technikfolgenabschätzung: Theorie und Praxis 13, 10-16.
78. Decker, M., Ladikas, M. (eds.) (2004) Bridges between Science, Society and Policy: Technology Assessment - Methods and Impacts, Berlin.
79. DEEPEN (2009) Reconfiguring Responsibility: Deepening Debate on Nanotechnology (www.geography.dur.ac.uk/projects/deepen).
80. DFG, Deutsche Forschungsgemeinschaft (2004) Tierversuche in der Forschung: Lemmens Verlag & Mediengesellschaft, Bonn
81. Drexler, K. E. (1986) Engines of Creation: The Coming Era of Nanotechnology, Oxford.
82. Dupuy, J.-P. (2005) The philosophical foundations of nanoethics. Arguments for a method. Lecture at the Nanoethics Conference, University of South Carolina, March 2-5, 2005.
83. Dupuy, J.-P. (2007) Complexity and uncertainty: a prudential approach to nanotechnology. In: Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.), Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey, pp. 119-132.
84. Dupuy, J.-P., Grinbaum, A. (2004) Living with uncertainty: toward the ongoing normative assessment of nanotechnology, Techné 8(2), 4-25; reprinted in: Schummer, I., Baird, D. (eds.) (2006), Nanotechnology Challenges: Implications for Philosophy, Ethics and Society, Singapore, pp. 287-314.
85. Durbin, P. (ed.) (1987) Technology and Responsibility, Dordrecht.
86. Ebbesen, M., Andersen, S., Besenbacher, F. (2006) Ethics in nanotechnology: starting from scratch? Bulletin of Science, Technology & Society 26, 451-462.
87. Edwards, S. (2006) The Nanotech Pioneers: Where Are They Taking Us? Weinheim.
88. EGE, European Group on Ethics in Science and New Technologies (2005) Ethical aspects of ICT implants in the human body. Opinion No. 20, Brussels.
89. Eigler, D. M., Schweizer, E. K. (1990) Positioning single atoms with a scanning tunneling Microscope. Nature 344, 524-526.
90. Engelhardt, T. (1976) Ideology and etiology. The Journal of Medicine and Philosophy 1, 256-268.
91. Engelhardt, T. (1982) The roles of values in the discovery of illnesses, diseases, and disorders. In: Beauchamp, T., Walters, L. (eds.), Contemporary Issues in Bioethics, Belmont, pp. 73-75.
92. Engels, E.-M. (2008) Was und wo ist ein »naturalistischer Fehlschluss«? Zur Definition und Identifikation eines Schreckgespenstes der Ethik. In: Brand, C., Engels, E.-M., Ferrari, A., Kovács, L. (eds.), Wie funktioniert Bioethik? Paderborn, pp. 125-141.
93. ENRHES, (2010) Engineered Nanoparticles: Review of Health and Environmental Safety. Project Report (http://nmi.jrc.ec.europa.eu/ documents/pdf/ENRHES%20pdf).
94. EPTA, European Parliamentary Technology Assessment Network (2006) ICT and Privacy in Europe (www.eptanetwork.org).
95. ESF, European Science Foundation (2005) Nanomedicine: An ESF Forward Look (www.esf.org/publications/forward-looks.html).
96. ETC, The Et-cetera Group (2003) From genomes to atoms. The Big Down: Atomtech -Technologies Converging at the Nano-scale (www.etcgroup.org).
97. ETC, The Et-cetera Group (2004) Down on the farm. The Impact of Nano-Scale Technologies on Food and Agriculture (www.etcgroup.org).
98. ETC, The Et-cetera Group (2007) Extreme genetic engineering. An Introduction to Synthetic Biology (www.etcgroup.org).
99. ETPN, European Technology Platform Nanomedicine (2005) Vision Paper and Basis for a Strategic Research Agenda for NanoMedicine (http:// www.etp-nanomedicine.eu/public/press-documents/publications/ etpn-publications).
100. European Commission (2004) Towards a European strategy on nanotechnology. COM 338, Brussels.
101. European Commission (2008) Recommendations toward a code of conduct for nanotechnology. COM 424, Brussels.
102. Fadeel, B., Garcia-Bennett, A. E. (2010) Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Advanced Drug Delivery Reviews 62(3), 362-74.
103. FAO, Food and Agriculture Organization (2006) Livestock's Long Shadow: Environmental Issues and Options (http://www.fao.org/docrep/010/a0701e/a0701e00.htm).
104. Farah, M. J., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., Parens, E., Sahakian, B., Wolpe, P. R. (2004) Neurocognitive enhancement: what can we do and what should we do? Nature Reviews: Neuroscience 5, 421-425.
105. Felt, U., Fochler, M., Müller, A., Strassnig, M. (2009) Unruly ethics: on the difficulties of a bottom-up approach to ethics in the field of genomics. Public Understanding of Science 18(3), 354-371.
106. Ferrari, A. (2008) Genmaus & Co: Gentechnisch veränderte Tiere in der Biomedizin. Harald Fischer Verlag, Stuttgart.
107. Ferrari, A. (2010) The control nano-freak: multifaceted strategies for taming nature. In: Kjolberg, K., Wickson, F. (2009), Nano Meets Macro: Social Perspectives on Nano-Scaled Sciences & Technologies, Singapore.
108. Ferrari, A., Coenen, C., Grunwald, A., Sauter, A. (2010) Animal Enhancement: Neue technische Möglichkeiten und ethische Fragen, Bern.
109. Feynman, R. P. (1959) Lecture given at 29.12.1959 at the annual meeting of the American Physical Society at Pasadena (http://www.zyvex.com/ nanotech/feynman.html).
110. Fiedeler, U. (2008) The Role of Nanotechnology in Chemical Substitution, European Parliament, Brussels.
111. Fiedeler, U., Coenen, C., Davies, S. R., Ferrari, A. (eds.) (2010) Understanding Nanotechnology: Philosophy, Policy and Publics, Heidelberg.
112. Fleischer, T. (2003) Technikgestaltung für mehr Nachhaltigkeit: Nanotechnologie. In: Coenen, R., Grunwald, A. (eds.), Nachhaltigkeitsprobleme in Deutschland. Analyse und Lösungsstrategien, Berlin, pp. 356-373.
113. Fleischer, T., Grunwald, A. (2008) Making nanotechnology developments sustainable. A role for technology assessment? Journal of Cleaner Production 16, 889-898.
114. Fleischer, T., Hocke, P., Kastenholz, H., Krug, H., Quendt, C., Spangenberg, A. (2010) Evidenzbewertung von Gesundheitsrisiken synthetischer Nanopartikel. In: Aichholzer, G., Bora, A., Bröchler, S., Decker, M., Latzer, M. (eds.), Technology Governance: Der Beitrag der Technikfolgenabschätzung, Berlin.
115. Foladori, G. (2008) Converging technologies and the poor: the case of nanomedicine and nanobiotechnology. In: Banse, G., Grunwald, A., Hronszky, I., Nelson, G. (eds.), Assessing Societal Implications of Converging Technological Development, Berlin, pp. 193-216.
116. Foladori, G., Invernizzi, N. (2007) Nanotechnology and developing countries: will nanotechnology overcome poverty or widen disparities? Nanotechnology Law and Business 2, Paper 11.
117. Frankena, W. (1939) The naturalistic fallacy. Mind 48, 464-477.
118. Freitas, R. A. Jr. (1999) Nanomedicine, Vol. I: Basic Capabilities, Georgetown, TX.
119. Freitas, R. A. Jr. (2003) Nanomedicine, Vol. IIA: Biocompatibility, Georgetown, TX.
120. Friends of the Earth (2006) Nanomaterials, sunscreens, and cosmetics: Small Ingredients (http://www.foe.org/camps/comm/nanotech/ nanocosmetics.pdf).
121. Fuentes, R., et al. (2009) Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science 323(5921), 1578-1582.
122. Funtowitz, S., Ravetz, J. (1993) The emergence of post-normal science. In: von Schomberg, R. (eds.), Science, Politics and Morality, London.
123. Gannon, F. (2003) Nano-nonsense (editorial). EMBO Reports 4(11), 1007.
124. Gee, D., Greenberg, M. (2002) Asbestos: from "magic" to malevolent mineral. In: Harremoes, P., et al. (eds.), The Precautionary Principle in the 20th Century: Late Lessons from Early Warnings, London, pp. 49-63.
125. Gehlen, A. (1986) Der Mensch: Seine Natur und seine Stellung in der Welt, Wiesbaden.
126. Geiser, M., Kreyling, W. G. (2010) Deposition and biokinetics of inhaled nanoparticles. Particle and Fibre Toxicology 7, 2.
127. Gerlinger, K., Petermann, T., Sauter, A. (2008) Gene Doping: Scientific Basis - Gateways - Monitoring. Technology Assessment Report 3, Office of Technology Assessment at the German Bundestag, Berlin (http://www. bundestag.de/htdocs_e/bundestag/committees/a18/translations/ gene_doping.pdf).
128. Gethmann, C. F. (1979) Protologik: Untersuchungen zur formalen Pragmatik von Begründungsdiskursen, Frankfurt.
129. Gethmann, C. F., Mittelstraß, J. (1992) Umweltstandards. GAIA 1(1992), 16-25.
130. Giddens, A. (1984) The Constitution of Society: Outline of the Theory of Structuration, Cambridge.
131. Goodman, N. (1954) Fact, Fiction, and Forecast.
132. Goodsell, D. S. (2004) Bionanotechnology: Lessons from Nature, New York.
133. Gottweis, H. (2008) Participation and the new governance of life. BioSocieties 3, 265-286.
134. Grin, J., Grunwald, A. (eds.) (2000) Vision Assessment: Shaping Technology in 21st Century Society, Berlin.
135. Grobe, A. (2007) Europa setzt auf Dialoge: Neue Wege der (Risiko-) kommunikation für Nanotechnologien. In: Gazsó, A., Greßler, S., Schiemer, F. (eds.), Nano. Chancen und Risiken aktueller Technologien, Wien, pp. 199-214.
136. Grolle, J. (2010) Konkurrenz für Gott. DER SPIEGEL 1/2010, 110-119.
137. Grunwald, A. (1999) Verantwortungsbegriff und Verantwortungsethik. In: Grunwald, A. (ed.), Rationale Technikfolgenbeurteilung, Berlin, pp. 172-195.
138. Grunwald, A. (2003) Methodical reconstruction of ethical advises. In: Bechmann, G., Hronszky, I. (eds.), Expertise and Its Interfaces, Berlin, pp. 103-124.
139. Grunwald, A. (2004) Strategic knowledge for sustainable development: the need for reflexivity and learning at the interface between science and society. International Journal of Foresight and Innovation Policy 1(1/2), 150-167.
140. Grunwald, A. (2005) Nanotechnology: a new field of ethical inquiry? Science and Engineering Ethics 11, 187-201.
141. Grunwald, A. (2006a) Nanotechnologie als Chiffre der Zukunft. In: Nordmann, A., Schummer, J., Schwarz, A. (eds.), Nanotechnologien im Kontext, Berlin, pp. 49-80.
142. Grunwald, A. (2006b) Technikfolgenabschätzung als Nachhaltigkeitsbewertung. Konzeptionelle Herausforderungen und methodische Probleme. In: Kopfmüller, J. (Hg.), Ein Konzept auf dem Prüfstand: Das integrative Nachhaltigkeitskonzept in der Forschungspraxis, Berlin, pp. 39-61.
143. Grunwald, A. (2007a) Converging technologies: visions, increased contingencies of the conditio humana, and search for orientation. Futures 39, 380-392.
144. Grunwald, A. (2007b) Working towards sustainable development in the face of uncertainty and incomplete knowledge. Journal of Environmental Policy & Planning 9, 245-262.
145. Grunwald, A. (2008a) Technik und Politikberatung: Philosophische Perspektiven, Frankfurt.
146. Grunwald, A. (2008b) Ethics of nanotechnology state of the art and challenges ahead. In: Schmid, G., et al. (eds.), Nanotechnology. Vol. 1: Principles and Fundamentals, Weinheim, pp. 245-286.
147. Grunwald, A. (2008c) Nanoparticles: risk management and the precautionary principle. In: Jotterand, F. (ed.), Emerging Conceptual, Ethical and Policy Issues in Bionanotechnology, Berlin, pp. 85-102.
148. Grunwald, A. (2008d) Ethical guidance for dealing with unclear risk. In: Wiedemann, P., Schütz, H. (eds.), The Role of Evidence in Risk Characterization: Making Sense of Conflicting Data, Weinheim, pp. 185-202.
149. Grunwald, A. (2009a) Technology assessment: concepts and methods. In: Meijers, A. (ed.), Philosophy of Technology and Engineering Sciences, Vol. 9, Amsterdam, pp. 1103-1146.
150. Grunwald, A. (2009b) Vision assessment supporting the governance of knowledge - the case of futuristic nanotechnology. In: Bechmann, G., Gorokhov, V., Stehr, N. (eds.), The Social Integration of Science: Institutional and Epistemological Aspects of the Transformation of Knowledge in Modern Society, Berlin, pp. 147-170.
151. Grunwald, A. (2010a) From speculative nanoethics to explorative philosophy of nanotechnology. NanoEthics 4(2), 91-101.
152. Grunwald, A. (2010b) Virtualisierung von Kommunikation und Handeln im Pervasive Computing - Schritte zur Technisierung des Menschen? In: Bölker, M., Gutmann, M., Hesse, W. (eds.), Information und Menschenbild, Berlin, pp. 79-101.
153. Grunwald, A. (2011a) Chances and risks of nanotechnology. In: Sattler, K. D. (ed.), Handbook of Nanophysics: Nanomedicine and Nanorobotics, Boca Raton, FL, pp. 13-1-13-16.
154. Grunwald, A. (2011b) Ten years of research on nanotechnology and society: outcomes and achievements. Proceedings of the 2nd S.NET Conference, Darmstadt 2010 (in press).
155. Grunwald, A., Hocke-Bergler, P. (2010) The risk debate on nanoparticles: contribution to a normalisation of the science/society relationship? In: Kaiser, M., Kurath, M., Maasen, S., Rehmann-Sutter, Ch. (eds.), Governing Future Technologies: Nanotechnology and the Rise of an Assessment Regime, Dordrecht, pp. 157-177.
156. Grunwald, A., Julliard, Y. (2007) Nanotechnology: steps towards understanding human beings as technology? NanoEthics 1, 77-87.
157. Grunwald, A., Kopfmüller, J. (2006) Nachhaltigkeit, Frankfurt/New York.
158. Guston, D. (2010) Encyclopedia of Nanoscience and Society, London.
159. Gutmann, M. (2004) Erfahren von Erfahrungen: dialektische Studien zur Grundlegung einer philosophischen Anthropologie, Bielefeld.
160. Habermas, J. (1970) Toward a Rational Society, Beacon Press, First publication. In: Habermas, J. (ed.) (1968) Technik und Wissenschaft als »Ideologie«, Frankfurt.
161. Habermas, J. (1973) Wahrheitstheorien. In: Fahrenbach, H. (ed.) Wirklichkeit und Reflexion. Walther Schulz zum sechzigsten Geburtstag, Pfullingen, pp. 211-265.
162. Habermas, J. (1988) Theorie des kommunikativen Handelns, Frankfurt, English version: The Theory of Communicative Action.
163. Habermas, J. (2001) Die Zukunft der menschlichen Natur, Frankfurt, English version: The Future of the Human Nature, Polity Press.
164. Hampp, N., Noll, F. (2003) Nanobionics II - from molecules to applications. Physik Journal 2(2), 56.
165. Hansson, S. O. (2006) Great uncertainty about small things. In: Schummer, J., Baird, D. (eds.) Nanotechnology Challenges - Implications for Philosophy, Ethics and Society, Singapore, pp. 315-325.
166. Hansson, S. O. (2010) Risk and safety in technology. In: Meijers, A. (ed.) Philosophy of Technology and Engineering Sciences, Vol. 9, Amsterdam, pp. 1069-1102.
167. Harremoes, P., Gee, D., MacGarvin, M., Stirling, A., Keys, J., Wynne, B., Guedes Vaz, S. (eds.) (2002) The Precautionary Principle in the 20th Century: Late Lessons from Early Warnings, London.
168. Harris, J. (1975) The survival lottery. Philosophy 50, 81-87.
169. Hatsopoulos, N. G., Donoghue, J. P. (2009) The science of neural interface systems. Annual Review of Neurosciences 32, 249-266.
170. Haum, R., Petschow, U., Steinfeldt, M., von Gleich, A. (2004) Nanotechnology and regulation within the framework of the precautionary principle. IÖW 173/04, Berlin.
171. Heckl, W. (2004) Molecular self-assembly and nanomanipulation - two key technologies in nanoscience and templating. Advanced Engineering Materials 6, 843-847.
172. Hennen, L., Grünwald, R., Revermann, C., Sauter, A. (2007) Hirnforschung. Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag, Berlin (www.tab-beim-bundestag.de).
173. Hermerén, G. (2003) Ethical implications of nanotechnology. Lecture given at EuroNanoForum, Trieste, 9-12 December 2003.
174. Hermerén, G. (2004) Nano ethics primer. Conference "Mapping out nano risks," Brussels, March 1, 2004.
175. Hildt, E. (2009) Fremdes im Gehirn. In: Engels, E., Hildt, E. (eds.) Der implantierte Mensch, Tübingen.
176. Hildt, E., Engels, E.-M. (Hg.) (2009) Der implantierte Mensch, Freiburg.
177. Höffe, O., et al. (Hg.) (2002) Gentechnik und Menschenwürde: An den Grenzen von Ethik und Recht, Köln.
178. Holm, S. (2005) Does nanotechnology require a new "nanoethics"? Paper published by Cardiff Centre for Ethics, Law & Society, August 2005.
179. Holtug, N. (1996) Is welfare all that matters in our moral obligations to animals? Acta Agriculturae Scandinavica Sect. A, Animal Science Supplement 27, 16-21.
180. Hook, C. (2004) The techno sapiens are coming. Christianity Today Magazine, January 2004.
181. Hornberg-Schwetzel, S. (2008) Therapie und Enhancement. Der Versuch einer wertvollen Unterscheidung, Jahrbuch für Wissenschaft und Ethik 2008, Bonn, Institut für Wissenschaft und Ethik, pp. 207-221.
182. Hubig, C. (2007) Die Kunst des Möglichen II: Ethik der Technik als provisorische Moral, Bielefeld.
183. Ilulissat Statement (2008) Synthesizing the future: a vision for the convergence of synthetic biology and nanotechnology. Kavli Futures Symposium "The merging of bio and nano: towards cyborg cells," 11-15 June 2007, Ilulissat, Greenland.
184. Invernizzi, N. (2008) Nanotechnology for developing countries. Asking the wrong question. In: Banse, G., Grunwald, A., Hronszky, I., Nelson, G. (eds.) Assessing Societal Implications of Converging Technological Development, Berlin, pp. 229-239.
185. IPCS (2004) Risk Assessment Terminology - Part 1 and Part 2, Geneva, Switzerland, World Health Organization
186. IRGC, International Risk Governance Council (2009) Risk Governance of Synthetic Biology, Genf
187. Irrgang, B. (2005) Posthumanes Menschsein?: Künstliche Intelligenz, Cyberspace, Roboter, Cyborgs und Designer-Menschen Anthropologie des künstlichen Menschen im 21. Jahrhundert, Stuttgart.
188. ITA, Institute of Technology Assessment at the Austrian Academy of Sciences (2010), Nano-dossiers (http://nanotrust.ac.at/nano.ita.en/ dossiers.html).
189. Janich, P., Rüchardt, C. (eds.) (1996) Natürlich, technisch, chemisch: Verhältnisse zur Natur am Beispiel der Chemie, Berlin.
190. Janich. P. (2006) Wissenschaftstheorie der Nanotechnologie. In: Nordmann, A., Schummer, J., Schwarz, A. (eds.) Nanotechnologien im Kontext, Berlin, pp. 1-32.
191. Jasanoff, S. (1990) The Fifth Branch: Science Advisers as Policymakers, Cambridge, MA.
192. Jasanoff, S. (2009) The essential parallel between science and democracy. Seed Magazine, http://seedmagazine.com/content/article/the_essential_ parallel_between_science_and_democracy.
193. JCP (2008) Sustainable nanotechnology development. Journal of Cleaner Production 16. Special issue.
194. Jömann, N., Ach, J. S. (2006) Ethical implications of nanobiotechnology - State-of-the-art survey of ethical issues related to nanobiotechnology. In: Ach, J., Siep, L. (eds.) Nano-bio-ethics. Ethical and Social Dimensions of Nanobiotechnology, Berlin, pp. 13-62.
195. Jonas, H. (1979/1984) The imperative of responsibility (1984) Jonas, H. (1979) Das Prinzip Verantwortung. Versuch einer Ethik für die technologische Zivilisation, Frankfurt.
196. Jonas, H. (1987) Lasst uns einen Menschen klonieren. Von der Eugenik zur Gentechnologie. In: Jonas, H. (ed.) Medizin und Ethik. Zur Praxis des Prinzips Verantwortung, Frankfurt, pp. 162-203.
197. Jones, R. A. L. (2004) Soft machines. Nanotechnology and Life, Oxford.
198. Joseph, T., Morrison, M. (2006) Nanotechnology in Agriculture and Food. A Nanoforum Report, http://files.nanobio-raise.org/nfnaf.pdf.
199. Jotterand, F. (ed.) (2008a) Emerging Conceptual, Ethical and Policy Issues in Bionanotechnology, Berlin.
200. Jotterand, F. (2008b) Beyond therapy and enhancement: the alteration of human nature. Nanoethics 2, 15-23.
201. Joy, B. (2000) Why the future does not need us. Wired Magazine, pp. 238-263.
202. Kaiser, M., Kurath, M., Maasen, S., Rehmann-Sutter, C. (eds.) (2010) Governing Future Technologies: Nanotechnology and the Rise of an Assessment Regime, Dordrecht.
203. Kamlah, W. (1973) Philosophische Anthropologie: Sprachkritische Grundlegung und Ethik, Mannheim.
204. Karafyllis, N. C. (2006) Biofakte. Grundlagen, Probleme und Perspektiven. Erwägen Wissen Ethik (EWE) 17(4), 547-558.
205. Karafyllis, N. C. (2008) Ethical and epistemological problems of hybridizing living beings: biofacts and body shopping. In: Wenchao, Li, Poser, H. (eds.) Ethical considerations on today's science and technology. A German-Chinese Approach, Münster, pp. 185-198.
206. Karpowicz, P., et al. (2005) Developing human-nonhuman chimeras in human stem cell research: ethical issues and boundaries. Kennedy Institute of Ethics Journal 15, 107-134.
207. Kastenhofer, K., Lansu, A., van Dam-Mieras, R. and Sotoudeh, M. (2010) The contribution of university curricula to engineering education for sustainable development. GAIA 19(1), 44-51; see also other contributions in that volume.
208. Keeney, R. L. (1984) Ethics, decision analysis, and public theory. Risk Analysis 4(1984), 117-129.
209. Keiper, A. (2007) Nanoethics as a discipline? The new Atlantis. A Journal of Technology & Science, 55-67.
210. Khushf, G. (2004a) The ethics of nanotechnology - visions and values for a new generation of science and engineering. In: National Academy of Engineering (ed.) Emerging Technologies and Ethical Issues in Engineering, Washington, pp. 29-55.
211. Khushf, G. (2004b) Systems theory and the ethics of human enhancement: a framework for NBIC convergence, Annals of the New York Academy of Sciences 1013, pp. 124-149.
212. Khushf, G. (2007) The ethics of NBIC convergence. Journal of Medicine and Philosophy 32/3, 185-196.
213. Kobayawa, K., Kobayakawa, R., Matsumoto, H., et al. (2007) Innate versus learned odour processing in the mouse olfactory bulb. Nature 450(7169), 503-508.
214. Koch, C. (2004) The Quest for Consciousness. A Neurobiological Approach, Englewood Colorado.
215. Kraft, J. C., et al. (2009) In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid. Neuroscience 161(3), 940-949.
216. Kralj, M., Pavelic, K. (2003) Medicine on a small scale. How molecular medicine can benefit from self-assembled and nanostructured materials. EMBO reports 4, 1008-1012.
217. Krug, H. F., Fleischer, T. (2007) Nanotechnologie - eine Bestandsaufnahme. Umwelt - Medizin - Gesellschaft 20, 44-50.
218. Kurath, M. (2010) Negotiating nano: from assessing risks to disciplinary transformations. In: Kaiser, M., Kurath, M., Maasen, S., Rehmann-Sutter, Chr. (eds.), Governing Future Technologies: Nanotechnology and the Rise of an Assessment Regime, Dordrecht.
219. Kurath, M., Maasen, S. (2006) Toxicology as a nanoscience? Disciplinary identities reconsidered. Particle and Fibre Toxicology 3, 6.
220. Latour, B. (1987) Science in Action: How to Follow Scientists and Engineers through Society, Harvard.
221. Latour, B. (1995) Wir Sind Nie Modern Gewesen, Berlin.
222. Lau, C. (2002) Nanotechnology and the Department of Defense. In: Roco, M. C., Bainbridge, W. S. (eds.), Converging Technologies for Improving Human Performance, Virginia, pp. 308-309.
223. Laurent, L., Petit, J.-C. (2006) Nanosciences and their convergence with other technologies: new golden age or apocalypse? In: Schummer, J., Baird, D. (eds.), Nanotechnology Challenges: Implications for Philosophy, Ethics and Society, Singapore, pp. 249-286.
224. LBNL, Lawrence Berkeley National Laboratory (2006) Homepage (http:// www.lbl.gov/pbd/synthbio/default.htm).
225. Lenk, H. (1992) Zwischen Wissenschaft und Ethik, Frankfurt.
226. Lewenstein, V. B. (2006) What counts as a "social and ethical issue" in nanotechnology? In: Schummer, J., Baird, D. (eds.), Nanotechnology Challenges: Implications for Philosophy, Ethics and Society, Singapore, pp. 201-216.
227. Lin, P., Allhoff, F. (2007) Nanoscience and nanoethics: defining the disciplines. In: Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.), Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey, pp. 3-16.
228. Link, H.-J. (2010) In-depth analysis of outstanding philosophical issues. In: Synth-Ethics: Report on Work Package 1 (http://www.synthethics.eu/ documents/REPORT WP1 synthethics - ethics+public discourse.pdf).
229. Lorenzen, P. (1987) Lehrbuch der konstruktiven Wissenschaftstheorie, Mannheim.
230. Lösch, A. (2008) The defuturization of the media: dynamics in the visual constitution of nanotechnology. In: Maasen, S., Rehmann-Sutter, C. (eds.), Deliberating Future Technologies: Identity, Ethics, and Governance.
231. Luhmann, N. (1997) Theorie der Gesellschaft, Frankfurt.
232. MacDonald, C. (2004) Nanotech is novel; the ethical issues are not. The Scientist 18, 3.
233. Macnaghten, P., Davies, S., Kearnes, N. (2010) Narrative and public engagement: some findings from the DEEPEN project. In: von Schomberg, R., Davies, S. (eds.) Understanding Public Debate on Nanotechnologies, European Commission, Brussels, EUR 24169, pp. 13-30.
234. Marchant, D., Sylvester, G., Abbott, K. (2008) Risk Management Principles of Nanotechnology (http://www.law.upenn.edu/academics/institutes/regulation/papers/MarchantRiskManagementPrinciples.pdf).
235. Marcinkowski, F., Kohring, M., Friedemann, A., Donk, A. (2008) Risikowahrnehmung beim Thema Nanotechnologie: Analyse der Medienberichterstattung für den Analysezeitraum 1/2006 - 6/2007, Berlin.
236. Margolis, J. (1981) The concept of disease. In: Caplan, A. (ed.), Concepts of Health and Disease: Interdisciplinary Perspectives, Reading, pp. 561-577.
237. Margolis, J. (1981) The concept of disease. In: Caplan, A. (ed.), Concepts of Health and Disease: Interdisciplinary Perspectives, Reading, pp. 561-577.
238. Marquis, B. J., Love, S. A., Braun, K. L., Haynes, C. L. (2009) Analytical methods to assess nanoparticle toxicity. Analyst 134(3), 425-439.
239. Maurer, S., Lucas, K., Terrel, S. (2006) From Understanding to Action: Community-Based Options for Improving Safety and Security in Synthetic Biology, Berkeley.
240. Maynard, A. D., Aitken, R. J., Butz, T., Colvin, V., Donaldson, K., Oberdorster, G., et al. (2006) Safe handling of nanotechnology. Nature 444(7117), 267-269.
241. Mehta, M. D. (2002) On nano-panopticism: a sociological perspective. Canadian Chemical News 54(10), 31-33.
242. Merkel, R., Galert, T., et al. (2007) Intervening in the Brain: Changing Psyche and Society, Berlin.
243. Meyer, R., Bütschi, D., Gram, S., Haugen, J. M., Sauter, A., Steyaert, St., Torgersen, H. (2009): Genetically Modified Plants and Foods: Challenges and Future Issues in Europe, Final Report, EPTA, Berlin (www.eptanetwork.org).
244. Miller, S., Selgelid, M. (2006) Ethics and the Dual-Use Dilemma in the Life Sciences, Berlin.
245. Mitcham, C. (1994) Thinking through Technology: The Path between Engineering and Philosophy, Chicago.
246. Mitcham, C., Briggle, A. (2010) The interaction of ethics and technology in historical perspective. In: Meijers, A. (ed.), Philosophy of Technology and Engineering Sciences, Vol. 9, Amsterdam, pp. 1147-1192.
247. Mittelstraß, J. (1991) Auf dem Wege zu einer Reparaturethik? In: Wils, J.-P., Mieth, D. (eds.), Ethik ohne Chance? Erkundungen im technologischen Zeitalter, Tübingen, pp. 89-108.
248. Mnyusiwalla, A., Daar, A. S., Singer, P. A. (2003) Mind the gap: science and ethics in nanotechnology. Nanotechnology 14, R9-R13.
249. Monteiro-Riviere, N. A., Tran, C. L. (eds.) (2007) Nanotoxicology: Characterization, Dosing and Health Effects, New York.
250. Moor, J., Weckert, J. (2004) Nanoethics: assessing the nanoscale from an ethical point of view. In: Baird, D., Nordmann, A., Schummer, J. (eds.), Discovering the Nanoscale, Amsterdam, pp. 301-310.
251. Moore, D. (2007) Nanotechnology and the military. In: Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.), Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey, pp. 267-275.
252. Moritz, C. T., Perlmutter, S. I., Fetz, E. E. (2008) Direct control of paralysed muscles by cortical neurons. Nature 456(7222), 639-642.
253. Moshammer, H., Wallner, P. (2007) Gesundheitsrisiken durch Nanopartikel? In: Gazsó, A., Greßler, S., Schiemer, F. (eds.), Nano. Chancen und Risiken aktueller Technologien, Wien, pp. 165-180.
254. Müller, S. (2006) Minimal-invasive und nanoskalige Therapien von Gehirnerkrankungen: Eine medizinethische Diskussion. In: Nordmann, A., Schummer, J., Schwarz, A. (eds.) Nanotechnologien im Kontext, Berlin, pp. 346-370.
255. Munich Re (2002) Nanotechnology: What Is in Store for Us? (http://www.munichre.com/publications/302-03534_en.pdf).
256. Myhr, A. I., Dalmo, R. A. (2007) Nanotechnology and risk: what are the issues? In: Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.) Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey, pp. 149-159.
257. Nachtigall, W. (2002) Bionik: Grundlagen und Beispiele für Ingenieure und Naturwissenschaftler, Berlin.
258. Nair, I., Morgan, G., Florig, H. K. (1989) Biologic Effects of Power Frequency Electric and Magnetic Fields. Office of Technology Assessment Report OTA-BP-E-53, Washington, DC.
259. Nanoforum (2004) Nanotechnology: Benefits, Risks, Ethical, Legal, and Social Aspects of NANOTECHNOLOGY (www.nanoforum.org).
260. Neuberger, M. (2007) Umweltepidemiologie und Toxikologie von Nanopartikeln (Ultrafeinstaub) und Feinstaub. In: Gazsó, A., Greßler, S., Schiemer, F. (eds.) Nano - Chancen und Risiken aktueller Technologien, Wien, pp. 181-197.
261. Neumann, S. (2008) Cosmetic surgery: customer service or professional misconduct. Canadian Veterinary Journal 49(5), 501-504.
262. Nida-Rümelin, J. (ed.) (1996a) Angewandte Ethik: Die Bereichsethiken und ihre theoretische Fundierung, Stuttgart.
263. Nida-Rümelin, J. (1996b) Risikoethik. In: Nida-Rümelin, J. (ed.) Angewandte Ethik: Die Bereichsethiken und ihre theoretische Fundierung, Stuttgart, pp. 863-887.
264. NNI (1999) National Nanotechnology Initiative, Washington
265. Nordenfelt, L. (1993) Quality of Life, Health, and Happiness, Avebury.
266. Nordmann, A. (2004) Converging Technologies: Shaping the Future of European Societies, High Level Expert Group "Foresighting the New Technology Wave," Brussels.
267. Nordmann, A. (2007a) If and then: a critique of speculative nanoethics. NanoEthics 1, 31-46.
268. Nordmann, A. (2007b) Entflechtung - Ansätze zum ethischgesellschaftlichen Umgang mit der Nanotechnologie. In: Gazsó, A., Greßler, S., Schiemer, F. (eds.) Nano: Chancen und Risiken aktueller Technologien, Wien, pp. 215-229.
269. Nordmann, A. (2008) Philosophy of "nanotechnoscience." In: Schmid, G. (ed.) Nanotechnology: Principles and Fundamentals, Weinheim, pp. 217-244.
270. Nordmann, A. (2010) A Forensic of wishing: technology assessment in the age of technoscience. Poiesis & Praxis 7, 5-15.
271. Nordmann, A., Rip, A. (2009) Mind the gap revisited. Nature Nanotechnology 4, 273-274.
272. Nordmann, A., Schummer, J., Schwarz, A. (eds.) (2006) Nanotechnologien im Kontext: Philosophische, ethische und gesellschaftliche Perspektiven, Berlin.
273. Nowotny, H., Scott, P., Gibbons, M. (2001) Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty, London.
274. Nuffield Council of Bioethics (2005) The Ethics of Research Involving Animals, Nuffield Council on Bioethics, London (http://www.nuffieldbioethics. org/fileLibrary/pdf/RIA_Report_FINAL-opt.pdf).
275. Oberdorster, G. (2010) Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. Journal of Internal Medicine, 267(1), 89-105.
276. Oberdörster, G., Oberdörster, E., Oberdörster, J. (2005) Nanotechnology: an emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives 113(7), 823-839.
277. Oertel, D., Grunwald, A. (2006) Potenziale und Anwendungsperspektiven der Bionik, Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB), Berlin.
278. Oppenheim, P., Putnam, H. (1958) The Unity of Science as a Working Hypothesis, Minnesota.
279. Pacurari, M., Castranova, V., Vallyathan, V. (2010) Single- and multi-wall carbon nanotubes versus asbestos: are the carbon nanotubes a new health risk to humans? Journal of Toxicology and Environmental Health, Part A 73(5), 378-395.
280. Parens, E. (ed.) (1998) Enhancing Human Traits: Ethical and Social Implications, Washington, DC.
281. Parens, E., Johnston, J., Moses, J. (2009) Ethical Issues in Synthetic Biology: An Overview of the Debates. Woodrow Wilson International Center for Scholars (http://www.synbioproject.org/library/publications/ archive/synbio3/).
282. Paschen, H., Coenen, C., Fleischer, T., Grünwald, R., Oertel, D., Revermann, C. (2004) Nanotechnologie: Forschung und Anwendungen, Berlin.
283. Pedrono, E., Durukan, A., Strbian, D., et al. (2010) An optimized mouse model for transient ischemic attack. Journal of Neuropathological Experimental Neurology 69(2), 188-195.
284. Pereira, A. G., von Schomberg, R., Funtowicz, S. (2007) Foresight knowledge assessment. International Journal of Foresight and Innovation Policy 4, 65-79.
285. Perelmann, C. (1967) Justice, New York.
286. Petersen, A., et al. (2009) Opening the black box: scientists' views on the role of the news media in the nanotechnology debate. Public Understanding of Science 18, 512-530.
287. Peterson, M. (2007) The precautionary principle should not be used as a basic for decision-making. EMBO Reports 8, 10-14.
288. Phoenix, C., Treder, M. (2003) Applying the precautionary principle to nanotechnology (http://www.crnano.org/Precautionary.pdf).
289. Picht, G. (1971) Prognose Utopie Planung, Stuttgart.
290. Presidential Commission (2010) Recommendations on Synthetic Biology, Washington
291. Psarros, N. (2006) Diskussionsbeitrag. Erwägen Wissen Ethik (EWE) 17, 594-596.
292. Qiu, L. (2006) Mighty mouse. Nature 444, 814-816.
293. Quante, M. (1994) Natur, Natürlichkeit und der naturalistische Fehlschluß. Zur begrenzten Brauchbarkeit eines klassischen philosophischen Arguments in der biomedizinischen Ethik. Zeitschrift für Medizinische Ethik 40, 289-305.
294. Radder, H. (2010) Why technologies are inherently normative. In: Meijers, A. (ed.), Philosophy of Technology and Engineering Sciences, Vol. 9, Amsterdam, pp. 887-922.
295. Renn, O., Roco, M. C. (2006) The risk governance of nanotechnology. Journal of Nanoparticle Research 8(2), 153-191.
296. Renn, O., Schweizer, P. J., Dreyer, M., Klinke, A. (2008) Risiko: Über den gesellschaftlichen Umgang mit Unsicherheit, München.
297. Rescher, N. (1983) Risk: A Philosophical Introduction to the Theory of Risk Evaluation and Management, Lanham.
298. Rescher, N. (1988) Rationality: A Philosophical Inquiry into the Nature and the Rationale of Reason, Oxford.
299. Reuter, K. (2007) Tierzucht für den ökologischen Landbau: Probleme, offene Fragen, Lösungsansätze. Bochum (http://orgprints.org/15131/1/ reuter-etal-2007-Tagungsband_Tierzucht_Kassel.pdf).
300. Reuzel, R. P. B. (2001) Health Technology Assessment and Interactive Evaluation: Different Perspectives, Nijmegen.
301. Rip, A., Swierstra, T. (2007) Nano-ethics as NEST-ethics: patterns of moral argumentation about new and emerging science and technology. NanoEthics 1, 3-20.
302. Rip, A., Misa, T., Schot, J. (eds.) (1995) Managing Technology in Society, London.
303. Rippe, K.-P. (2002) Vorsorge als umweltethisches Problem. Im Auftrag der Eidgenössischen Ethikkommission für den außerhumanen Bereich (www.ethikdiskurs.ch/Umweltethik/Vorsorgeprinzip.pdf).
304. Roache, R. (2008) Ethics, speculation, and values. Nanoethics 2, 317-327.
305. Robert, J. S., Baylis, F. (2003) Crossing species boundaries. The American Journal of Bioethics 3(3), 1-13.
306. Robischon, M. (2007) Von Fischen und genen. Amazonas 14 (November/ Dezember 2007), Seite 64-68; (http://www.amazonas-magazin.de/ index.php?id=1142).
307. Roco, M. C. (2007) Foreword: ethical choices in nanotechnology development. In: Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.) Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey, p. 5f.
308. Roco, M. C., Bainbridge, W. S. (eds.) (2001) Societal Implications of Nanoscience and Nanotechnology, Boston.
309. Roco, M. C., Bainbridge, W. S. (eds.) (2002) Converging Technologies for Improving Human Performance, Arlington.
310. Rohbeck, J. (1993) Technologische Urteilskraft: Zu einer Ethik technischen Handelns, Frankfurt.
311. Rolston, H. (1988) Environmental Ethics, Philadelphia.
312. Ropohl, G. (1996) Ethik und Technikbewertung, Frankfurt.
313. Rorty, R. (1998) Truth and Progress: Philosophical Papers, Cambridge.
314. Royal Society (2004) Nanoscience and Nanotechnologies: Opportunities and Uncertainties, London
315. Sandel, M. (2004) The Case Against Perfection, Boston.
316. Sarewitz, D., Karas, T. H. (2006) Policy Implications of Technologies for Cognitive Enhancement, Arizona State University, Consortium for Science, Policy & Outcomes.
317. Sattler, K. D. (ed.) (2011) Handbook of Nanophysics: Nanomedicine and Nanorobotics, Boca Raton, FL.
318. Schepelmann, P., Ritthoff, M., Jeswani, H., Azapagic, A., Suomalainen, K. (2009) Options for deepening and broadening LCA. CALCAS - Coordination Action for Innovation in Life-Cycle Analysis for Sustainability, Brussels.
319. Schmid, G. (ed.) (2008) Nanotechnology: Principles and Fundamentals, Weinheim.
320. Schmid, G., Decker, M. (eds.) (2003) Small Dimensions and Material Properties: A Definition of Nanotechnology, Bad Neuenahr-Ahrweiler.
321. Schmid, G., Ernst, H., Grünwald, W., Grunwald, A., et al. (2006) Nanotechnology: Perspectives and Assessment, Berlin.
322. Schmidt, K. (2008) Tierethische Probleme der Gentechnik: Zur moralischen Bewertung der Reduktion wesentlicher tierischer Eigenschaften, Mentis, Paderborn.
323. Schmidt, J. (2002) Vom Leben zur Technik? Kultur- und wissenschaftsphilosophische Aspekte der Natur-Nachahmungsthese in der Bionik. Dialektik 2, 129-143.
324. Schmidt, J. C. (2008) Unbestimmtheitssignaturen der Nanotechnologie. In: Köchy, K., Norwig, M., Hofmeister, G. (eds.), Nanobiotechnologien. Philosophische, anthropologische und ethische Fragen, Freiburg, pp. 47-66.
325. Schöne-Seifert, B., Ach, J. S., Talbot, D., Opolka, U. (eds.) (2009) Neuro Enhancement: Ethik vor neuen Herausforderungen, Paderborn.
326. Schummer, J. (2007) Impact of nanotechnologies on developing countries. In: Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.), Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey, pp. 291-307.
327. Schummer, J., Baird, D. (eds.) (2006) Nanotechnology Challenges: Implications for Philosophy, Ethics and Society, Singapore.
328. Scott, N. R. (2005) Nanotechnology and animal health. Revue Scientifique et Technique (International Office of Epizootics) 24(1), 425-432.
329. Scott, S. (2006) Converting thoughts into action. Nature 442, 141-142.
330. Seaton, A., Tran, L., Aitken, R., Donaldson, K. (2010) Nanoparticles, human health hazard and regulation. Journal of the Royal Society Interface 7(1), 119-129.
331. Seeman, N. C., Belcher, A. M. (2002) Emulating biology: building nanostructures from the bottom up. PNAS 99(2), 6451-6455.
332. Selgelid, M. (2007) Ethics and drug resistance. Bioethics 21, 218-221.
333. Selin, C. (2006) Time matters: harmony and dissonance in nanotechnology networks. Time & Society 15(1), 121-139.
334. Selin, C. (2007) Expectations and the emergence of nanotechnology. Science, Technology and Human Values 32(2), 196-220.
335. Sethe, S. (2007) Nanotechnology and life extension. In: Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.), Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey, pp. 353-365.
336. Sharp, P. A. (2005) 1918 flu and responsible science. Science 310(5745), 17.
337. Shrader-Frechette, K. S. (1991) Risk and rationality: Philosophical Foundations for Populist Reforms, Berkeley.
338. Shriver, A. (2009) Knocking out pain in livestock: can technology succeed where morality has stalled? Neuroethics 2, 115-124.
339. Shumyatsky, G. P., Malleret, G., Shin, R. M., et al. (2005) Stathmin, a gene enriched in the amygdala, controls both learned and innate fear. Cell 123, 697-709.
340. Siep, L. (2006) Die biotechnische Neuerfindung des Menschen. In: Abel, G. (ed.) Kreativität, Akten des XX. Deutschen Kongresses für Philosophie, Hamburg, pp. 306-323.
341. Simko, M., Mattsson, M.-O. (2010) Risks vom accidental exposures to engineered nanoparticles and neurological health effects: a critical review. Particle and Fibre Toxicology 7, 42-54.
342. Siune, K., Markus, E., Calloni, M., Felt, U., Gorski, A., Grunwald, Rip, A., de Semir, V., Wyatt, S. (2009) Challenging Futures of Science in Society, MASIS Expert Group, European Commission, Brussels.
343. Smalley, R. E. (2001) Of chemistry, love and nanobots. Scientific American 285, 76-77.
344. Stehr, N. (2004) The Governance of Knowledge, London.
345. Steinfeldt, M., Gleich, A. von, Petschow, U., Haum, R. (2007) Nanotechnologies, Hazards and Resource Efficiency, Heidelberg.
346. Stephens, L. F. (2005) News narratives about Nano S&T in major U.S. and Non-U.S. newspapers. Science Communication 27, 175-199.
347. Stern, P. C., Fineberg, H. V. (eds.) (1996) Understanding Risk: Informing Decisions in a Democratic Society, Washington DC.
348. Stieglitz, T. (2006) Neuro-technical interfaces to the central nervous system. Poiesis & Praxis 4, 95-110.
349. Stirling, A. (2008) "Opening up" and "closing down": power, participation, and pluralism in the social appraisal of technology. Science Technology Human Values 2008 33, 262-294.
350. Stø, E., Scholl, G., Jègou, F., Strandbakken, P. (2010) The future of deliberative processes on nanotechnology. In: von Schomberg, R. (ed.) Understanding Public Debate on Nanotechnologies. Options for Framing Public Policy, Brussels, pp. 53-80.
351. Sunstein, C. (2005) The Laws of Fear: Beyond the Precautionary Principle, Cambridge.
352. Swiss Re (2004) Nanotechnologie: Kleine Teile - große Zukunft? Risk Perception, Zürich
353. Synbiology (2005) SYNBIOLOGY (SYNBIOLOGY_Literature_And_Statistical_Review.pdf in www2.spi.pt/synbiology/documents/).
354. Synth-Ethics (2010) Homepage of the EU-funded project "Ethical and regulatory issues raised by synthetic biology" (http://synthethics. eu/).
355. Talwar, S. K., Xu, S., Hawley, E. S., et al. (2002) Behavioural neuroscience: rat navigation guided by remote control. Nature 417, 37-38.
356. Taniguchi, N. (1074) On the basic concept of "nano-technology". Proceedings of the International Conference on Production Engineering, Tokyo, Part II., Japan Society of Precision Engineering. ten Have, H. (Hg.) (2007) Nanotechnologies, Ethics and Politics, Paris.
357. Truin, M., van Kleef, M., Verboeket, Y., et al. (2009) The effect of spinal cord stimulation in mice with chronic neuropathic pain after partial ligation of the sciatic nerve. Pain 145(3), 312-318.
358. Tucker, J. B., Zilinskas, R. A. (2006) The promise and perils of synthetic biology. The New Atlantis 12, 25-45.
359. UK Govt., H. M. Government (2005) Response to the Royal Society and Royal Academy of Engineering Report (http://www.ost.gov.uk/policy/ issues/nanotech_final.pdf).
360. van de Poel, I. (2010) Values in engineering design. In: Meijers, A. (ed.) Philosophy of Technology and Engineering Sciences, Vol. 9, Amsterdam, pp. 973-1006.
361. van den Hoven, J. (2007) Nanotechnology and privacy: instructive case of RFID. In: Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.) Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey, pp. 253-266.
362. van Gorp, A. (2005) Ethical Issues in Engineering Design, Safety and Sustainability. Simon Stevin Series in the Philosophy of Technology, Delft/Eindhoven.
363. van Merkerk, R. (2007) Intervening in Emerging Technologies: A CTA of Labon-a-Chip Technology, Utrecht.
364. VDI, Verein Deutscher Ingenieure (1991), Richtlinie 3780 Technikbewertung, Begriffe und Grundlagen, Düsseldorf
365. VDI, Verein Deutscher Ingenieure (2000) Ethische Ingenieurverantwortung: Handlungsspielräume und Perspektiven der Kodifizierung. VDI-Report 31, Düsseldorf.
366. VDI-TZ (VDI-Technologiezentrum) (2002) Nanobiotechnologie I: Grundlagen und technische Anwendungen molekularer, funktionaler Biosysteme. Zukünftige Technologien 38, Düsseldorf.
367. Velliste, M., Perel, S., Spalding, M. C., et al. (2008) Cortical control of a prosthetic arm for self- feeding. Nature 453, 1098-1101.
368. von Gleich, A., Pade, C., Petschow, U., Pissarskoi, E. (2007) Bionik: Aktuelle Trends und zukünftige Potentiale, Bremen.
369. von Schomberg, R. (2005) The precautionary principle and its normative challenges. In: Fisher, E., Jones, J., von Schomberg, R. (eds.) The Precautionary Principle and Public Policy Decision Making, Cheltenham, UK/Northampton, MA, pp. 141-165.
370. von Schomberg, R. (2007) From the Ethics of Technology Towards an Ethics of Knowledge Policy & Knowledge Assessment. A Working Document from the European Commission Services, EUR 2429, Brussels.
371. von Schomberg, R., Davies, S. (eds.) (2010) Understanding Public Debate on Nanotechnologies, European Commission, EUR 24169, Brussels.
372. Wagner, P. (2005) Nanobiotechnology. In: Greco, R., Prinz, F. B., Lane, R. (eds.) Nanoscale Technology in Biological Systems, Boca Raton, FL, pp. 39-55.
373. Wardak, A. (2003) Nanotechnology and Regulation: A Case Study Using the Toxic Substance Control Act (TSCA), Woodrow Wilson International Center, Foresight and Governance Project, Paper 2003-6.
374. Warneken, F., Tomasello, M. (2006) Altruistic helping in human infants and young chimpanzees, Science 311(5765), 1301-1303.
375. WCED, World Commission on Environment and Development (1987), Our Common Future, Oxford
376. Weckert, J. (2007) Editorial. Nanoethics 1, 1-2.
377. Weckert, J., Moor, J. (2007) The precautionary principle in nanotechnology. In: Allhoff, F., Lin, P., Moor, J., Weckert, J. (eds.) Nanoethics: The Ethical and Social Implications of Nanotechnology, New Jersey, pp. 133-146.
378. Whitehouse, D. (2003) GM fish glows in the bowl, BBC News, 27 June 2003, (http://news.bbc.co.uk/2/hi/science/nature/3026104.stm).
379. Wiedemann, P., Schütz, H. (eds.) (2008) The Role of Evidence in Risk Characterization: Making Sense of Conflicting Data, Weinheim.
380. Williams, E., Frankel, M. S. (2006) Good, Better, Best: The Human Quest for Enhancement. Summary Report of an Invitational Workshop Convened by the Scientific Freedom, Responsibility and Law Program, American Association for the Advancement of Science.
381. Wilson, E. O. (1999) Consilience: The Unity of Knowledge, New York.
382. Winner, L. (1982) Autonomous Technology: Technics-Out-of-Control as a Theme in Political Thought, Cambridge.
383. Woese, C. R. (2004) A new biology for a new century. Microbiology and Molecular Biology Reviews 68(2), 173-186.
384. Wolbring, G. (2006) The Triangle of Enhancement Medicine, Disabled People, and the Concept of Health: A New Challenge for HTA, Health Research, and Health Policy, Alberta Heritage Foundation for Medical Research (AHFMR), Edmonton. HTA Initiative #23.
385. Wolbring, G. (2008a) Oscar Pistorius and the future nature of Olympic, Paralympic and other sports. SCRIPTed 5, 139-160.
386. Wolbring, G. (2008b) Why NBIC? Why human performance enhancement? The European Journal of Social Science Research 21, 25-40.
387. World Transhumanist Association (2006) For the ethical use of technology to extend human capabilities (www.transhumanism.org/index.php/ WTA/index/).
388. Wynne, B. (1991) Knowledges in context. Science, Technology and Human Values 16(4), 1-19.
389. Xia, T., Li, N., Nel, A. E. (2010) Potential health impact of nanoparticles. The Annual Review of Public Health 30, 137-150.
390. Yoshinaka, Y., Clausen, C., Hansen, A. (2003) The social shaping of technology: a new space for politics? In: Grunwald, A. (ed.) Technikgestaltung: Zwischen Wunsch oder Wirklichkeit, Berlin, pp. 117-131.
391. Zuin, S., Pojana, G., Marcomini, A. (2007) Effect-oriented physicochemical characterization of nanomaterials. In: Monteiro-Riviere, N. A., Tran, C.L. (eds.) Nanotoxicology: Characterization, Dosing and Health Effects, New York.